Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × niraparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 8 Prostatic Neoplasms 6 Neoplasms 4 Neoplasm Metastasis 4 Breast Neoplasms 4 Glioblastoma 3 Fallopian Tube Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 2 Pancreatic Neoplasms 2 Glioma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Ovarian Carcinosarcoma 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1

Interventions

olaparib 3 enzalutamide 2 Prednisone 2 Pluvicto 2 Abiraterone Acetate 2 testosterone 17 beta-cypionate 1 sarilumab 1 radium Ra 223 dichloride 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 darolutamide 1 cemiplimab 1 Radium-223 1 Prednisolone 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Cyclophosphamide 1 Blood Specimen Collection 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡